THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI enters new phase with €3.3 billion budget
IMI enters its second phase with a €3.3 billion budget & the ambitious goal of fast-tracking the development of the next generation of medicines, especially in areas of unmet need.
- 30/07/2014 : Newsletter highlight: IMI project NEWMEDS has developed a tool to spot patients enrolled in multiple clinical trials http://t.co/cEG0lXSlX4
- 30/07/2014 : Newsletter highlight: IMI project QuIC-ConCePT shows new technology to analyse cancer scans predicts disease progress http://t.co/cEG0lXSlX4
- 30/07/2014 : Our July newsletter is out, with news from the #IMI2 launch plus the latest from our amazing projects http://t.co/VcC9MPayAR